· Test device (individually in a foil pouch with desiccant) (20pcs)
· Single-Use Reaction tubes each with 400 ul extraction reagent (20 pcs)
· Disposable Tubes (20pcs)
· Package insert (1pcs)
· Sterile swabs (20 pcs)
The Diagnostic Kit for SARS-CoV-2 is a qualitative membrane-based immunoassay for the detection of SARS- CoV-2 in nasopharyngeal swab. In the Test region, anti-SARS-CoV-2 is coated. During testing, the specimen reacts with SARS-CoV-2 antibody-coated particles in the test strip.
The mixture then migrates upward on the membrane chromatographically by capillary action and reacts with the anti-SARS-CoV-2 in test line region.
Since the first outbreak reported in December 2019, SARS-CoV-2 has spread rapidly worldwide, and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). Due to its highly contagious nature and global health crises, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO). SARS-CoV-2 continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS- CoV-2 pandemic, systematic screening, and detection of both clinical and asymptomatic COVID-19 cases is critical. Particularly, the identification of subclinical or asymptomatic cases is important to reduce or stop the infection because these individuals may transmit the virus. the virus has spread globally and can cause mild to severe respiratory illness including death.
The SARS-CoV-2 Antigen Rapid Test is a rapid test, instrument-free, single-use molecular diagnostic test kit for the qualitative detection of SARS-CoV-2 RNA from self-collect nasal swab samples in individuals with known or suspected COVID-19. The test kit contains all the components required to perform testing.
The SARS-CoV-2 Antigen Rapid Test is a lateral flow immunochromatographic technology for the qualitative detection of nucleocapsid protein antigen test. The SARS-CoV-2 Antigen Rapid Test is designed to detect antigen from the SARS-CoV-2 in nasopharyngeal swabs specimens from patients who are suspected of COVID-19 by their healthcare provider within five days of symptom onset.
To perform the test, nasopharyngeal swabs specimen is collected from the patient, sample preparation step in which the sample is eluted into the extraction buffer solution. Extracted swab sample is added to the sample well of the test device to initiate the test. When the swab sample migrates in the test strip, SARS- CoV-2 viral antigens bind to anti-SARS-CoV-2 nucleocapsid protein antibodies conjugated to indicator and capture particles in the test strip forming an immune complex.
To order your test today, Call Coastal Drug Testing TODAY at (800) 221-4291
And remember, “When You Need A Test, Choose The Best”